A Triple-blind randomized controlled trial on the effects of turmeric versus ginger on inflammatory biomarkers in patients with COVID-19.
- 2025-08-21
- RCT · n = 144
- Scientific reports 15(1)
- Zahra Saleh
- Mohammad Reza Asgari
- Raheb Ghorbani
- Hassan Babamohamadi
- PubMed: 40841392
- DOI: 10.1038/s41598-025-16092-4
- High evidence
- Large Human Trial
- Rigorous Journal
- Clinical
Changes in CRP and ESR varied significantly across groups (p < 0.001), with greater reductions observed in the turmeric and ginger groups compared to the placebo group (p < 0.001), and no difference between the turmeric and ginger groups (CRP: p = 0.263; ESR: p > 0.99).
- Effect
- Beneficial
- Effect size
- Moderate
- Significant
- Yes
- Dose
- three 500 mg tablets daily for five days (15 tablets total)